Selective Serotonin Reuptake Inhibitor Discontinuation: Side Effects and Other Factors That Influence Medication Adherence
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Patients with major depression discontinue taking their antidepressants for many reasons. Although side effects are often cited as the reason for discontinuation, few prospective studies have addressed this question, and none has specifically examined discontinuation in patients with severe depression. METHOD: Inpatients and outpatients treated with a selective serotonin reuptake inhibitor for major depressive disorder were identified after admission. Three months later, patients were contacted and interviewed to determine antidepressant usage and the side effects experienced, including when these were experienced and their severity. RESULTS: Between October 2001 and April 2003, 406 English- or Spanish-speaking patients aged 18 to 75 years were followed up. One in 4 patients discontinued the index antidepressant. Among specific side effects noted, only "change in weight" and "anxiety" were significant predictors of discontinuation after controlling for confounders. Experiencing 1 or more "extremely" bothersome side effects was associated with more than a doubling of the risk of discontinuation, but the presence of side effects and side effects less severe than "extremely" bothersome were not significant predictors. There were no differences among selective serotonin reuptake inhibitor antidepressants in either the presence/absence of side effects or in the discontinuation rates. CONCLUSION: The results suggest that the contribution of side effects to antidepressant discontinuation is more complex than previously suggested. Disparate findings from earlier studies may reflect aspects of study design, such as examining populations whose severity of depression varied widely or not controlling for important confounding factors. Future research should separately examine high-risk groups (or control for severity of depression) and carefully rule out other potential contributors to discontinuation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as well as problems with adherence and financial burden [15,16].”
From Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods (2018) · cites this paper as [15]
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
The Role of the Primary Care Physician in Patientsʼ Adherence to Antidepressant Therapy
LIN, E. H. B., KORFF, M. V., KATON, W., BUSH, T., SIMON, G. E., WALKER, E., & ROBINSON, P. (1995) · Medical Care · doi:10.1097/00005650-199501000-00006 · Cited by 587
Confounding by Indication: An Example of Variation in the Use of Epidemiologic Terminology
Salas, M., Hotman, A., & Stricker, B. H. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009758 · Cited by 471 · cited 1×
“Alternatively, the association between benzodiazepine use and SSRI discontinuation may be due to confounding by indication.(33,34) In this case, SSRI side effects associated with SSRI discontinuation may have been treated with benzodiazepines, resulting in a spurious association between benzodiazepine use and SSRI dis…”
BackgroundWeight gain and antidepressants.
D, M. F. M. (2000) · PubMed · Cited by 388
Bull, S. A., Hu, X. H., Hunkeler, E. M., Lee, J. Y., Ming, E. E., Markson, L. E., & Fireman, B. (2002) · JAMA · doi:10.1001/jama.288.11.1403 · Cited by 359 · cited 2×
“This finding is in contrast to previous reports in which these side effects were not associated with SSRI discontinuation.(2,3,21) Also different from earlier studies is the finding that dry mouth, reported by more than 50% of this study’s patients, was not associated with discontinuation.”
ResultAntidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320 · cited 2×
“This finding is in contrast to previous reports in which these side effects were not associated with SSRI discontinuation.(2,3,21) Also different from earlier studies is the finding that dry mouth, reported by more than 50% of this study’s patients, was not associated with discontinuation.”
ResultAnderson, I. M., & Tomenson, B. M. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 306
Shapiro, S. (1997) · PubMed · Cited by 299
The many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288 · cited 1×
“The results presented here may also differ because previous samples were less severely depressed and/or were distributed over a wide range of severity.(2,3,13,18,19) All available data indicated that depression among patients in this study was nearly uniformly severe; GAF scores at admission were low (95% had GAF e50)…”
ResultHu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0712 · Cited by 235 · cited 2×
“This finding is in contrast to previous reports in which these side effects were not associated with SSRI discontinuation.(2,3,21) Also different from earlier studies is the finding that dry mouth, reported by more than 50% of this study’s patients, was not associated with discontinuation.”
ResultCompliance during treatment with antidepressants
Demyttenaere, K. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)00095-x · Cited by 165
Fluoxetine versus phenelzine in atypical depression
Pande, A. C., Birkett, M. A., Fechner-Bates, S., Haskett, R. F., & Greden, J. F. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00628-1 · Cited by 150
The compliance with antidepressants in general practice
Maddox, J. C., Levi, M., & Thompson, C. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800108 · Cited by 148
Optimizing outcomes in depression: focus on antidepressant compliance
Keller, M. B., Hirschfeld, R. M. A., Demyttenaere, K., & Baldwin, D. S. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00001 · Cited by 142
Hotopf, M., Hardy, R., & Lewis, G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.2.120 · Cited by 142
Escitalopram continuation treatment prevents relapse of depressive episodes
Rapaport, M. H., Bose, A., & Zheng, H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0107 · Cited by 121
Thompson, C., Peveler, R. C., Stephenson, D., & McKendrick, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.338 · Cited by 103
Out-patient Compliance with Antidepressant Medication
Myers, E. D., & Branthwaite, A. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.1.83 · Cited by 94
Problems with currently available antidepressants.
Gumnick, J. F., & Nemeroff, C. B. (2000) · PubMed · Cited by 80
Beasley, C. M., Koke, S. C., Nilsson, M., & Gonzales, J. S. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)83028-3 · Cited by 79
Bolling, M. Y., & Kohlenberg, R. J. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000080392 · Cited by 74 · cited 1×
“However, for the purposes of this study, patients’ assessments of side effects were likely to influence decisions to discontinue treatment and thus were important predictors.(23) The exact timing of all side effects could not be confirmed, although we asked patients to report side effects caused by their SSRI.”
MethodCompliance in depressed patients treated with fluoxetine or amitriptyline
Demyttenaere, K., Ganse, E. V., Gregoire, J., Gaens, E., & Mesters, P. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199801000-00002 · Cited by 71 · cited 1×
“Our finding that sex (male) and age (younger) were associated with greater likelihood of SSRI discontinuation is consistent with a previous study comparing amitriptyline with fluoxetine.(9) Many individual and classes of treatments were examined, including uses of a second SSRI, a non-SSRI antidepressant, a tricyclic…”
ResultPredictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression
McGrath, P. J., Stewart, J. W., Petkova, E., Quitkin, F. M., Amsterdam, J. D., Fawcett, J., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0710 · Cited by 65
Beasley, C. M., Nilsson, M. E., Koke, S. C., & Gonzales, J. S. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1003 · Cited by 62 · cited 1×
“Possible explanations for the disparity between these results and those from many previous studies include the population and outcome (eg, discontinuation versus continuation, discontinuation versus switching versus continuation, adherence to regimen) examined,2,3,9,10 extent to which investigators have controlled for…”
ResultGartlehner, G., Hansen, R. A., Carey, T. S., Lohr, K. N., Gaynes, B. N., & Randolph, L. C. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200503000-00001 · Cited by 60 · cited 2×
“The results presented here may also differ because previous samples were less severely depressed and/or were distributed over a wide range of severity.(2,3,13,18,19) All available data indicated that depression among patients in this study was nearly uniformly severe; GAF scores at admission were low (95% had GAF e50)…”
ResultCompliance With Pharmacotherapy in Mood Disorders
Basco, M. R., & Rush, A. J. (1995) · Psychiatric Annals · doi:10.3928/0048-5713-19950501-03 · Cited by 56 · cited 1×
“The results presented here may also differ because previous samples were less severely depressed and/or were distributed over a wide range of severity.(2,3,13,18,19) All available data indicated that depression among patients in this study was nearly uniformly severe; GAF scores at admission were low (95% had GAF e50)…”
ResultEarly Termination of Antidepressant Drug Treatment
Linden, M., Gothe, H., Dittmann, R. W., & Schaaf, B. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00005 · Cited by 56
Compliance: the impact of adverse events and tolerability on the physician’s treatment decisions
Roose, S. P. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00097-x · Cited by 54
Long-term management of chronic depression.
Nierenberg, A. A. (2001) · PubMed · Cited by 49
Adverse events and treatment discontinuations in fluoxetine clinical trials
Pande, A. C., & Sayler, M. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00010 · Cited by 42
Demyttenaere, K., Albert, A., Mesters, P., Mesters, P., Dewé, W., Bruyckere, K. D., & Sangeleer, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0708 · Cited by 36
High Medication Discontinuation Rates in Psychiatry: How Often Is It Understandable?
Mitchell, A. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000205845.36042.ba · Cited by 35
Ackerman, D. L., Greenland, S., Bystritsky, A., & Small, G. W. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00012 · Cited by 24
Research works printed but not linked: 2
- Bull, 2002, Discontinuing or switching selective serotonin-reuptake inhibitors., Ann Pharmacother, 36, 578, 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
- Anderson, 1995, Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis., BMJ, 310, 1433, 10.1136/bmj.310.6992.1433 · DOI · Paper page
Cited by
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800
Medication Adherence: A Review of the Literature and Implications for Clinical Practice
Julius, R. J., Novitsky, M. A., & Dubin, W. R. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000344917.43780.77 · Cited by 301
Persistence and compliance to antidepressant treatment in patients with depression: A chart review
Sawada, N., Uchida, H., Suzuki, T., Watanabe, K., Kikuchi, T., Handa, T., & Kashima, H. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-38 · Cited by 216
New Roles for Pharmacists in Community Mental Health Care: A Narrative Review
Rubio-Valera, M., Chen, T., & O'Reilly, C. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph111010967 · Cited by 199
“Lack of adherence to psychotropic medicines remains a highly prevalent problem [54–62].”
BackgroundCurcumin for depression: a meta-analysis
Fusar-Poli, L., Vozza, L., Gabbiadini, A., Vanella, A., Concas, I., Tinacci, S., Petralia, A., Signorelli, M. S., & Aguglia, E. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1653260 · Cited by 183
“However, lack of adherence to antidepressant medications is frequent (Sansone and Sansone 2012), and the presence of adverse effects seems to be one of the main causes (Goethe et al. 2007).”
Background
Metadata
- Authors
- Goethe, J. W., Woolley, S. B., Cardoni, A. A., Woznicki, B. A., & Piez, D. A.
- Affiliations
- Hartford Hospital (US)
- Corresponding author
- Woolley, Stephen B.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2007-10
- Volume
- 27
- Issue
- 5
- Pages
- 451-458
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1981417884
- Cited by
- 113
- References
- 33
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 8 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 14 · 2012: 4
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- selective serotonin reuptake inhibitors, antidepressant discontinuation, major depressive disorder, antidepressant side effects, weight change, anxiety, severe depression, predictors of discontinuation
- MeSH terms
- Adolescent, Adult, Aged, Anxiety, Body Weight, Major Depressive Disorder, Depressive Disorder, Major, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Multivariate Analysis, Treatment Refusal, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.